Balyasny Asset Management LLC Cytokinetics Inc Transaction History

Balyasny Asset Management LLC

$54.9 Billion
Q2 2024

A detailed history of Balyasny Asset Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 201,100 shares of CYTK stock, worth $10.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

201,100

Previous 675,062 70.21%

Holding current value

$10.5 Million

Previous $47.3 Million 76.98%

% of portfolio

0.02%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $3.53 Million - $5.53 Million	-73,695 Reduced 10.92%	601,367 $32.6 Million
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $16.7 Million - $28.3 Million	261,925 Added 63.4%	675,062 $47.3 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $20.6 Million - $63.9 Million	-765,741 Reduced 64.96%	413,137 $34.5 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $3.16 Million - $3.93 Million	107,346 Added 10.02%	1,178,878 $34.7 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $3.9 Million - $4.87 Million	119,528 Added 12.56%	1,071,532 $35 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $2.36 Million - $3.23 Million	70,596 Added 8.01%	952,004 $33.5 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $21.4 Million - $30.6 Million	598,160 Added 211.18%	881,408 $40.4 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $3.65 Million - $5.16 Million	94,609 Added 50.15%	283,248 $13.7 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $6.4 Million - $9.23 Million	188,639 New	188,639 $7.41 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $294,753 - $455,906	-9,911 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $927,587 - $1.25 Million	-27,004 Reduced 73.15%	9,911 $452,000
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $684,404 - $1.32 Million	36,915 New	36,915 $1.32 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $1.91 Million - $3.58 Million	-125,298 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $2.58 Million - $3.63 Million	125,298 New	125,298 $2.71 Million
Q1 2018 May 15, 2018	SELL	$7.2 - $10.05 $143,114 - $199,763	-19,877 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$7.25 - $15.65 $5.96 Million - $12.9 Million	-822,118 Reduced 97.64%	19,877 $162,000
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $10.1 Million - $12.6 Million	841,995	841,995 $12.2 Million

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

126M

Call Options Held

3.29M

Put Options Held

2.01M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.93B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Cytokinetics Inc Transaction History